All the news Showing 10 of 725 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatocellular carcinoma (HCC) Higher HIV viral load and lower CD4 count linked to liver cancer risk Liz Highleyman / 14 March 2019 People living with HIV who have a longer duration of detectable viral load and those with low CD4 cell counts have a higher likelihood of developing liver cancer in the absence of ... Treatment for people who use drugs HCV reinfection in people who inject drugs a sign of a successful treatment programme, say researchers Keith Alcorn / 11 March 2019 High rates of reinfection in people who inject drugs are a sign that access to treatment is improving, not a sign of failure, and should prompt retreatment, not stigmatisation, Australian hepatitis researcher ... Sex between men Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up Liz Highleyman / 07 March 2019 New cases of hepatitis C virus (HCV) infection among HIV-positive gay and bisexual men seen at three clinics in London have declined by nearly 70% since 2015, according to a presentation yesterday ... Treatment for people who use drugs Access to hepatitis C care boosted for people who inject drugs by specialist nurses Keith Alcorn / 19 February 2019 People attending specialist addiction centres in England where a facilitator enabled access to hepatitis C care services were ten times more likely to be referred to hepatology services and to start treatment ... Treatment outcomes DAA treatment reduces the risk of death and liver cancer in France Keith Alcorn / 12 February 2019 Treatment with direct-acting antivirals (DAAs) reduced the risk of death, liver cancer and death from liver-related causes in French people with hepatitis C, according to results of one of the largest studies ... Screening and testing policy Tackling HIV and hepatitis C in Europe: towards minimum standards Gus Cairns / 11 February 2019 Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form the basis of a European-wide ... Diabetes Hepatitis C cure does not improve glucose control in type 2 diabetes Michael Carter / 07 February 2019 A successful response to hepatitis C virus (HCV) therapy does not result in long-term improvements in glucose metabolism for people with type 2 diabetes, according to US research published in Liver International. A sustained ... Hepatocellular carcinoma (HCC) Immunotherapy combinations show promise for liver cancer Liz Highleyman / 04 February 2019 Checkpoint inhibitor immunotherapy combinations may slow disease progression in people with hepatocellular carcinoma (HCC), according to two small studies presented at the 2019 Gastrointestinal Cancers Symposium last month in San Francisco. However, response ... Treatment outcomes Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost Michael Carter / 01 February 2019 Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in Liver International. Generics achieved ... NAFLD Experimental therapy improves liver health in people with fatty liver disease Liz Highleyman / 31 January 2019 NGM282, an experimental fibroblast growth factor analogue, reduced liver fat build-up and the development of scar tissue in people with non-alcoholic steatohepatitis, according to studies presented at the recent AASLD Liver Meeting in ... ← Prev12345...73Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds